Program
R-3750
A development code.
Its studies are mostly in Crohn Disease · Colitis, Ulcerative · Respiratory Distress Syndrome · Pulmonary Disease, Chronic Obstructive, led by Rise Therapeutics.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Rise Therapeutics | 44 open or running | phase 1since Dec 1, 2022 | Dec 1, 2022 | Apr 30, 2028phase 1 · NCT07076290 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Dec 1, 2022First study: phase 1 study in Colitis, UlcerativeFirst studyNCT05666960 · 36 planned · United States
- Jul 14, 2025Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT07076290 · 27 planned
- Jun 5, 2026Phase 1 study in Respiratory Distress SyndromeNCT07646028 · 20 planned
- Aug 18, 2026Phase 1 study in Crohn DiseaseNCT07791888 · 40 planned
Ahead
- Apr 30, 2028Primary completion: phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT07076290
- Oct 31, 2028Primary completion: phase 1 study in Respiratory Distress SyndromeNCT07646028
- Dec 31, 2028Primary completion: phase 1 study in Crohn DiseaseNCT07791888
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07791888Crohn Disease | 1 | Not yet recruiting | Dec 31, 2028 | 40 |
| NCT07646028Respiratory Distress Syndrome | 1 | Not yet recruiting | Oct 31, 2028 | 20 |
| NCT07076290Pulmonary Disease, Chronic Obstructive | 1 | Not yet recruiting | Apr 30, 2028 | 27 |
| NCT05666960Colitis, Ulcerative · United States | 1 | Recruiting | Jul 2026 | 36 |
How it is read
Names in the registry
- “R-3750”, 4 entries
Codes read as this program: R3750.
Conditions, from the studies’ own filings
- Crohn Disease, 1 study
- Colitis, Ulcerative, 1 study
- Respiratory Distress Syndrome, 1 study
- Pulmonary Disease, Chronic Obstructive, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.